Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ebastine' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 48 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Matsuda, M; Mizuki, Y; Terauchi, Y
      Simultaneous determination of the histamine H-1-receptor antagonist ebastine and its two metabolites, carebastine and hydroxyebastine, in human plasma using high-performance liquid chromatography

      JOURNAL OF CHROMATOGRAPHY B
    2. Malik, M
      Problems of heart rate correction in assessment of drug-induced QT interval prolongation

      JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    3. Rohatagi, S; Gillen, M; Aubeneau, M; Jan, C; Pandit, B; Jensen, BK; Rhodes, G
      Effect of age and gender on the pharmacokinetics of ebastine after single and repeated dosing in healthy subjects

      INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS
    4. Imamura, Y; Shimizu, K; Yamashita, F; Yamaoka, K; Takakura, Y; Hashida, M
      Transport characteristics of ebastine and its metabolites across human intestinal epithelial Caco-2 cell monolayers

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    5. Tagawa, M; Kano, M; Okamura, N; Higuchi, M; Matsuda, M; Mizuki, Y; Arai, H; Iwata, R; Fujii, T; Komemushi, S; Ido, T; Itoh, M; Sasaki, H; Watanabe, T; Yanai, K
      Neuroimaging of histamine H-1-receptor occupancy in human brain by positron emission tomography (PET): A comparative study of ebastine, a second-generation antihistamine, and (+)-chlorpheniramine, a classical antihistamine

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    6. Gillen, MS; Miller, B; Chaikin, P; Morganroth, J
      Effects of supratherapeutic doses of ebastine and terfenadine on the QT interval

      BRITISH JOURNAL OF CLINICAL PHARMACOLOGY
    7. Frossard, N; Vital-Durand, D; Mounedji, N; Valleteau, A
      Duration of the antihistaminic effect after discontinuation of ebastine

      ALLERGY
    8. DeBoer, DJ; Cooley, AJ
      Use of induced cutaneous immediate-type hypersensitivity reactions to evaluate anti-inflammatory effects of triamcinolone topical solution in three dogs

      VETERINARY DERMATOLOGY
    9. Frossard, N; Benabdesselam, O; Purohit, A; Mounedji, N; Pauli, G
      Activity of ebastine (10 and 20 mg) and cetirizine at 24 hours of a steadystate treatment in the skin of healthy volunteers

      FUNDAMENTAL & CLINICAL PHARMACOLOGY
    10. Herberg, KW
      Investigation of the effects of the antihistamine ebastine on safety in everyday life and road traffic

      ALLERGOLOGIE
    11. Ohmura, T; Nakamura, R; Watanabe, S; Ikeda, Y; Umemura, K; Hashimoto, H
      Comparative electrophysiological effects of the second generation antihistamines, astemizole and ebastine, in a canine myocardial infarction model

      DRUG DEVELOPMENT RESEARCH
    12. Frossard, N; Walsh, GM
      Comparing the H-1 profile of second-generation antihistamines

      ALLERGY
    13. Ratner, PH; Lim, JC; Georges, GC
      Comparison of once-daily ebastine 20 mg, ebastine 10 mg, loratadine 10 mg,and placebo in the treatment of seasonal allergic rhinitis

      JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
    14. Grant, JA; Danielson, L; Rihoux, JP; DeVos, C
      A comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo in suppressing the cutaneous response to histamine

      INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY
    15. Roberts, DJ; Gispert, J
      The non-cardiac systemic side-effects of antihistamines: ebastine

      CLINICAL AND EXPERIMENTAL ALLERGY
    16. Moss, AJ; Chaikin, P; Garcia, JD; Gillen, M; Roberts, DJ; Morganroth, J
      A review of the cardiac systemic side-effects of antihistamines: ebastine

      CLINICAL AND EXPERIMENTAL ALLERGY
    17. Ohtani, H; Sato, H; Iga, T; Kotaki, H; Sawada, Y
      Pharmacokinetic-pharmacodynamic analysis of the arrhythmogenic potency of a novel antiallergic agent, ebastine, in rats

      BIOPHARMACEUTICS & DRUG DISPOSITION
    18. Gras, J; Llenas, J
      Effects of H-1 antihistamines on animal models of QTc prolongation

      DRUG SAFETY
    19. Roberts, DJ
      Epilogue

      DRUG SAFETY
    20. Grant, JA; Danielson, L; Rihoux, JP; DeVos, C
      A double-blind, single-dose, crossover comparison of cetirizine, ebastine,epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine-induced wheal and flare response for 24 h in

      ALLERGY
    21. Bousquet, J; Gaudano, EM; Carlos, AGP; Staudinger, H
      A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis

      ALLERGY
    22. Roberts, DJ
      Cardiotoxicity of second-generation antihistamines

      DRUGS
    23. LEROY T; TASSET C; VALENTIN B; VANNESTE D
      COMPARISON OF THE EFFECTS OF CETIRIZINE AND EBASTINE ON THE SKIN-RESPONSE TO HISTAMINE IONTOPHORESIS MONITORED WITH LASER-DOPPLER FLOWMETRY

      Dermatology
    24. Bachert, C
      Histamine - a major role in allergy?

      CLINICAL AND EXPERIMENTAL ALLERGY
    25. Bousquet, J
      Antihistamines in severe/chronic rhinitis

      CLINICAL AND EXPERIMENTAL ALLERGY
    26. JANSAT JM; LASTRA CF; MARINO EL
      COMPARATIVE-STUDY OF DIFFERENT WEIGHTING METHODS IN NONLINEAR-REGRESSION ANALYSIS - IMPLICATIONS IN THE PARAMETRIZATION OF CAREBASTINE AFTER INTRAVENOUS ADMINISTRATION IN HEALTHY-VOLUNTEERS

      International journal of clinical pharmacology and therapeutics
    27. VERMEEREN A; OHANLON JF
      FEXOFENADINES EFFECTS, ALONE AND WITH ALCOHOL, ON ACTUAL DRIVING AND PSYCHOMOTOR PERFORMANCE

      Journal of allergy and clinical immunology
    28. MATSUNAGA K; SATO T; SHUTO H; TSURUTA Y; SUEMARU K; GOMITA Y; OISHI R
      INHIBITION OF NEURONAL DOPAMINE UPTAKE BY SOME ANTIALLERGIC DRUGS

      European journal of pharmacology
    29. VALENZUELA C; DELPON E; FRANQUEZA L; GAY P; VICENTE J; TAMARGO J
      COMPARATIVE EFFECTS OF NONSEDATING HISTAMINE H-1 RECEPTOR ANTAGONISTS, EBASTINE AND TERFENADINE, ON HUMAN KV1.5 CHANNELS

      European journal of pharmacology
    30. FUJII T; MATSUMOTO S; HATOYAMA T; MIYAZAKI H
      STUDIES ON THE FIRST-PASS METABOLISM OF EBASTINE IN RATS

      Arzneimittel-Forschung
    31. MARINO EL; JANSAT JM; MARCH MA; LASTRA CF
      PARAMETRIZATION BY NONLINEAR-REGRESSION ANALYSIS OF THE ACTIVE ACID METABOLITE OF EBASTINE USING DIFFERENT WEIGHTING METHODS

      International journal of clinical pharmacology and therapeutics
    32. WISEMAN LR; FAULDS D
      EBASTINE - A REVIEW OF ITS PHARMACOLOGICAL PROPERTIES AND CLINICAL EFFICACY IN THE TREATMENT OF ALLERGIC DISORDERS

      Drugs
    33. GRAS J; LLENAS J; PALACIOS JM; ROBERTS DJ
      THE ROLE OF KETOCONAZOLE IN THE QTC INTERVAL PROLONGING EFFECTS OF H-1-ANTIHISTAMINES IN A GUINEA-PIG MODEL OF ARRHYTHMOGENICITY

      British Journal of Pharmacology
    34. HEY JA; DELPRADO M; SHERWOOD J; KREUTNER W; EGAN RW
      COMPARATIVE-ANALYSIS OF THE CARDIOTOXICITY PROCLIVITIES OF 2ND-GENERATION ANTIHISTAMINES IN AN EXPERIMENTAL-MODEL PREDICTIVE OF ADVERSE CLINICAL ECG EFFECTS

      Arzneimittel-Forschung
    35. HEY JA; DELPRADO M; KREUTNER W; EGAN RW
      CARDIOTOXIC AND DRUG-INTERACTION PROFILE OF THE 2ND-GENERATION ANTIHISTAMINES EBASTINE AND TERFENADINE IN AN EXPERIMENTAL ANIMAL-MODEL OF TORSADE-DE-POINTES

      Arzneimittel-Forschung
    36. KII Y; INUI A; ITO T
      EFFECTS OF HISTAMINE H-1 RECEPTOR ANTAGONISTS ON ACTION-POTENTIALS INGUINEA-PIG ISOLATED PAPILLARY-MUSCLES

      Archives internationales de pharmacodynamie et de therapie
    37. HERNANDEZ DJC; AQILAR JLP; ROMERO JD; BAEHRE M
      COMPARISON OF AZELASTINE NASAL SPRAY AND ORAL EBASTINE IN TREATING SEASONAL ALLERGIC RHINITIS

      Current medical research and opinion
    38. OHANLON JF; RAMAEKERS JG
      ANTIHISTAMINE EFFECTS ON ACTUAL DRIVING PERFORMANCE IN A STANDARD TEST - A SUMMARY OF DUTCH EXPERIENCE, 1989-94

      Allergy
    39. DELACUADRA J; TERUEL M; TEIXIDO P; ROMA J
      ASSESSMENT OF THE WHEAL SIZE AND SKIN BLOOD-FLOW OF THE ERYTHEMA INDUCED BY HISTAMINE AND ITS MODIFICATION WITH CETIRIZINE AND EBASTINE - ACROSSOVER, DOUBLE-BLIND-STUDY

      Dermatology
    40. SIMONS FER
      THE THERAPEUTIC INDEX OF NEWER H-1-RECEPTOR ANTAGONISTS

      Clinical and experimental allergy
    41. KUITUNEN T
      DRUG AND ETHANOL EFFECTS ON THE CLINICAL-TEST FOR DRUNKENNESS - SINGLE DOSES OF ETHANOL, HYPNOTIC DRUGS AND ANTIDEPRESSANT DRUGS

      Pharmacology & toxicology
    42. PATAT A; GRAM LF; DUBRUC C; BROHIER S; CABANIS MJ; ROSENZWEIG P
      EFFECTS OF MIZOLASTINE, A NEW ANTIHISTAMINE, ON PSYCHOMOTOR PERFORMANCE AND MEMORY IN ELDERLY SUBJECTS

      International clinical psychopharmacology
    43. FUJII T; MATSUMOTO S; AMEJIMA H; HATOYAMA T; NAKAO M; KAGEMOTO A; TANAKA K; MIYAZAKI H
      ABSORPTION, DISTRIBUTION, METABOLISM AND EXCRETION OF [C-14] EBASTINEAFTER A SINGLE ADMINISTRATION IN RATS

      Arzneimittel-Forschung
    44. FUJII T; TANAKA K; MATSUMOTO S; HATOYAMA T; NOMURA T; TAGAWA M; MIYAZAKI H
      ABSORPTION, DISTRIBUTION, METABOLISM AND EXCRETION OF [C-14] EBASTINEAFTER REPEATED ORAL-ADMINISTRATION IN RATS

      Arzneimittel-Forschung
    45. MATSUDA M; SAKASHITA M; MIZUKI Y; YAMAGUCHI T; FUJII T; SEKINE Y
      COMPARATIVE PHARMACOKINETICS OF THE HISTAMINE H-1-RECEPTOR ANTAGONISTEBASTINE AND ITS ACTIVE METABOLITE CAREBASTINE IN RATS, GUINEA-PIGS, DOGS AND MONKEYS

      Arzneimittel-Forschung
    46. YAMAGUCHI T; HASHIZUME T; MATSUDA M; SAKASHITA M; FUJII T; SEKINE Y; NAKASHIMA M; UEMATSU T
      PHARMACOKINETICS OF THE H-1-RECEPTOR ANTAGONIST EBASTINE AND ITS ACTIVE METABOLITE CAREBASTINE IN HEALTHY-SUBJECTS

      Arzneimittel-Forschung
    47. BROOKHUIS KA; DEVRIES G; DEWAARD D
      ACUTE AND SUBCHRONIC EFFECTS OF THE H-1-HISTAMINE RECEPTOR ANTAGONISTEBASTINE IN 10, 20 AND 30 MG DOSE, AND TRIPROLIDINE 10 MG ON CAR DRIVING PERFORMANCE

      British journal of clinical pharmacology
    48. VANROOIJ J; SCHOEMAKER HC; BRUNO R; REINHOUDT JF; BREIMER DD; COHEN AF
      CIMETIDINE DOES NOT INFLUENCE THE METABOLISM OF THE H(1)-RECEPTOR ANTAGONIST EBASTINE TO ITS ACTIVE METABOLITE CAREBASTINE

      British journal of clinical pharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 16/01/21 alle ore 23:49:48